Huperzine A for vascular dementia (Q24241186)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Huperzine A for vascular dementia (English)

0 references

0 references

1 reference

Donghao Lv

4

0 references

author name string

Zilong Hao

series ordinal

1

0 references

Ming Liu

series ordinal

2

0 references

Zhiqin Liu

series ordinal

3

0 references

language of work or name

English

0 references

publication date

2009

0 references

published in

0 references

page(s)

CD007365

0 references

issue

2

0 references

cites work

Effects of Ginkgo biloba in dementia: systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Rivastigmine for vascular cognitive impairment

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

19 March 2017

Memantine for dementia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Donepezil for vascular cognitive impairment

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

An update on huperzine A as a treatment for Alzheimer's disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Vascular dementia: emerging trends

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Treatment of vascular dementia and vascular cognitive impairment

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

27 September 2017

Dementia: a brief review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Use of antidementia agents in vascular dementia: beyond Alzheimer disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Vascular dementia prevention: a risk factor analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Facts, myths, and controversies in vascular dementia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Incidence of vascular dementia in Rochester, Minn, 1985-1989.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Research criteria for subcortical vascular dementia in clinical trials

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Cerebral blood flow in dementia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Drug evaluation of huperzine A in the treatment of senile memory disorders

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Nimodipine for primary degenerative, mixed and vascular dementia

30 May 2018

2 references

https://api.crossref.org/works/10.1002%2F14651858.CD007365.PUB2

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4171119

Galantamine for vascular cognitive impairment

29 November 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007365.PUB2

21 January 2018

Memantine for dementia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007365.PUB2

Vascular cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007365.PUB2

Vascular cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007365.PUB2

Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007365.PUB2

Piracetam for dementia or cognitive impairment

21 January 2018

1 reference